Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication

Zhanghao Li,Feixia Wang,Baoyu Liang,Ying Su,Sumin Sun,Siwei Xia,Jiangjuan Shao,Zili Zhang,Min Hong,Feng Zhang,Shizhong Zheng

DOI: https://doi.org/10.1038/s41392-020-00349-7

IF: 39.3

2020-12-01

Signal Transduction and Targeted Therapy

Abstract:Abstract As one of the bicyclic metabolic pathways of one-carbon metabolism, methionine metabolism is the pivot linking the folate cycle to the transsulfuration pathway. In addition to being a precursor for glutathione synthesis, and the principal methyl donor for nucleic acid, phospholipid, histone, biogenic amine, and protein methylation, methionine metabolites can participate in polyamine synthesis. Methionine metabolism disorder can aggravate the damage in the pathological state of a disease. In the occurrence and development of chronic liver diseases (CLDs), changes in various components involved in methionine metabolism can affect the pathological state through various mechanisms. A methionine-deficient diet is commonly used for building CLD models. The conversion of key enzymes of methionine metabolism methionine adenosyltransferase (MAT) 1 A and MAT2A/MAT2B is closely related to fibrosis and hepatocellular carcinoma. In vivo and in vitro experiments have shown that by intervening related enzymes or downstream metabolites to interfere with methionine metabolism, the liver injuries could be reduced. Recently, methionine supplementation has gradually attracted the attention of many clinical researchers. Most researchers agree that adequate methionine supplementation can help reduce liver damage. Retrospective analysis of recently conducted relevant studies is of profound significance. This paper reviews the latest achievements related to methionine metabolism and CLD, from molecular mechanisms to clinical research, and provides some insights into the future direction of basic and clinical research.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: to explore the molecular mechanisms of methionine metabolism in chronic liver disease (CLD) and its therapeutic significance. Specifically, the article mainly focuses on the following aspects:

1. **Basic physiological roles of methionine metabolism**:
- Methionine metabolism includes the methionine cycle, the trans - sulfuration pathway and the salvage cycle.
- As an essential amino acid, methionine plays a crucial role in protein synthesis, S - adenosylmethionine (SAM) production and various biochemical reactions.

2. **The relationship between methionine metabolism disorders and chronic liver disease**:
- Methionine metabolism in patients with chronic liver disease will change, and these changes affect the pathological state through multiple mechanisms.
- For example, the conversion of methionine - metabolizing enzymes (such as methionine adenosyltransferase MAT1A and MAT2A/MAT2B) is closely related to fibrosis and hepatocellular carcinoma.

3. **The impact of interfering with methionine metabolism on chronic liver disease**:
- Studies have shown that interfering with methionine metabolism by interfering with related enzymes or downstream metabolites can reduce liver damage.
- Methionine supplements have gradually attracted the attention of clinical researchers, and most studies believe that an appropriate amount of methionine supplementation can help reduce liver damage.

4. **The interaction between methionine metabolism and other metabolic pathways**:
- There are complex interactions between methionine metabolism and the folate cycle, the trans - sulfuration pathway and other metabolic pathways.
- These interactions play an important role in the occurrence and development of chronic liver disease.

5. **Future research directions**:
- The article reviews the latest research results and provides insights for future basic and clinical research.
- In particular, in terms of molecular mechanisms and clinical applications, suggestions for further research are put forward.

In summary, this paper aims to comprehensively understand the role of methionine metabolism in chronic liver disease, from molecular mechanisms to clinical research, in order to discover new therapeutic targets and strategies, so as to better prevent and treat chronic liver disease.